Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|March 4, 2026
Pilot study: predicting the interplay between FOXO1 and its downstream long non-coding RNAs in HCCRowan Abdelbary, Sherine K Saber, Fabian Rose, et al.
Archives of Virology|April 6, 2019
Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell modelsRadwa Yehia Mekky, Nada El-Ekiaby, Shereen Ahmed El Sobky, et al.
Life Sciences|October 15, 2022
Regulation of IGF2BP1 by miR-186 and its impact on downstream lncRNAs H19, FOXD2-AS1, and SNHG3 in HCCDanira Ashraf Habashy, Merna Hatem Mohamed Hamad, Manon Ragheb, et al.
Biomedical Reports|October 4, 2014
Predictive prognostic role of miR-181a with discrepancy in the liver and serum of genotype 4 hepatitis C virus patientsDalia Sherif Elhelw, Radwa Yehia Mekky, Nada El-Ekiaby, et al.
Biomedical Reports|December 4, 2014
Expression signature of microRNA-155 in hepatitis C virus genotype 4 infectionSarah Ehab Riad, Nada El-Ekiaby, Radwa Yehia Mekky, et al.
BMC Gastroenterology|September 30, 2024
OncomiR-181a promotes carcinogenesis by repressing the extracellular matrix proteoglycan decorin in hepatocellular carcinomaReem Amr Assal, Rowan Bahaa El-Din Abd El-Bary, Rana A Youness, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|July 15, 2026
YAP/TAZ knockdown reduces lipid droplet accumulation in hepatic cells through a putative SBDSP1/miR-29a-5p/LDLR regulatory axisMerna H Hamad, Fabian Rose, Manon Ragheb, et al.
Pageof 3